Abstract:Capillary leak syndrome (CLS) is a rare disease with profound vascular leakage, which can be associated with a high mortality. There have been several reports on CLS as an adverse effect of anti-cancer agents and therapy, but the incidence of CLS according to the kinds of anti-cancer drugs has not been systemically evaluated. Thus, the aim of our study was to comprehensively meta-analyze the incidence of CLS by different types of cancer treatment or after bone marrow transplantation (BMT). We searched the literatures (inception to July 2018) and among 4612 articles, 62 clinical trials (studies) were eligible. We extracted the number of patients with CLS, total cancer patients, name of therapeutic agent and dose, and type of cancer. We performed a meta-analysis to estimate the summary effects with 95% confidence interval and between-study heterogeneity. The reported incidence of CLS was categorized by causative drugs and BMT. The largest number of studies reported on CLS incidence during interleukin-2 (IL-2) treatment (n = 18), which yielded a pooled incidence of 34.7% by overall estimation and 43.9% by meta-analysis. The second largest number of studies reported on anti-cluster of differentiation (anti-CD) agents (n = 13) (incidence of 33.9% by overall estimation and 35.6% by meta-analysis) or undergoing BMT (n = 7 (21.1% by overall estimation and 21.7% by meta-analysis). Also, anti-cancer agents, including IL-2 + imatinib mesylate (three studies) and anti-CD22 monoclinal antibodies (mAb) (four studies), showed a dose-dependent increase in the incidence of CLS. Our study is the first to provide an informative overview on the incidence rate of reported CLS patients as an adverse event of anti-cancer treatment. This meta-analysis can lead to a better understanding of CLS and assist physicians in identifying the presence of CLS early in the disease course to improve the outcome and optimize management.

Capillary leak syndrome: A rare cause of acute respiratory distress syndrome

Progress of Clinical Reaearch on Capillary Leak Syndrome

Idiopathic systemic capillary leak syndrome: a case report

Fluid Resuscitation of Capillary Leak Syndrome

[A case report of systemic capillary leak syndrome. Effective treatment with immunoadsorption and leukotriene antagonist].

Capillary Leak Syndrome Associated with Anaplastic T Cell Lymphoma and Transcutaneous Exudation: An Unusual Presentation

Systemic capillary leak syndrome due to systemic inflammatory response syndrome in infants: a report on 31 patients

The risk factors of capillary leak syndrome after extracorporeal bypass in infants

Ultrasound findings and specific intrinsic blood volume expansion therapy for neonatal capillary leak syndrome: report from a multicenter prospective self-control study

Malignant Hemispheric Cerebral Infarction Associated with Idiopathic Systemic Capillary Leak Syndrome

Adrenomedullin surges are linked to acute episodes of the systemic capillary leak syndrome (Clarkson disease)

Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis

A case of frequent of prerenal acute kidney injury attacks: importance of recognizing systemic capillary leak syndrome: a case report

Adult respiratory distress syndrome in pediatric patients. II. Management

Trastuzumab-Induced Systemic Capillary Leak Syndrome in a Breast Cancer Patient

P3.15-06 Capillary Leak Syndrome in a Primary Lung Adenocarcinoma Patient with Thrombocytopenia from Interleukin-11 Treatment

Abdominal Compartment Syndrome Associated with Capillary Leak Syndrome after Liver Transplantation.

Risk factors for capillary leak syndrome in children with tetralogy after operation]

[Clinical analysis of secondary hemophagocytic lymphohistiocytosis complicated with capillary leak syndrome].

Hypersensitive blood vessels in Clarkson disease

Idiopathic Systemic Capillary Leak Syndrome: Report of a Pediatric Case